DACH & BENELUX – Life Sciences Labour Market Trends, July 2024
DACH and BENELUX Face Decline, Projected Rebound in 2024
Key findings include:
- BENELUX shows a recovery increase of 18,3%, whilst DACH is up by 12.7%
- Germany makes up the biggest portion of the DACH region, accounting for 65.9%
- The Netherlands forecast an increase in vacancies by 42.2%.
- Top Company: DACH – Eurofins, up by 40,8%; BENELUX – Merck, up by 39.2%
DOWNLOAD THE REPORT
DOWNLOAD THE REPORT
The 2023 year saw a dip across both DACH and BENELUX regions, reflected by the EU data. DACH has kept higher numbers than BENELUX since the start of 2022, but this gap is now shortening whilst still being apparent. So far, the first half 2024 is projected to see lower volumes than the full-year estimate.
So with that being said, the EU market saw a decline of 32% from 2022 to 2023 but is projected to rebound with a 25.2% increase in 2024 – on top of this, the DACH region experienced an even steeper decline of 38.1% from 2022 to 2023 but is expected to see a more modest recovery of 12.7% in 2024, compared to BENELUX which is forecast to recover with an 18.3% increase in 2024. This is according to the latest Life Sciences Labour Market Trends report by Cpl and market data analysts Vacancysoft.
DACH Job Market Volatile, Projected Rebound in 2024
Germany makes up the largest portion of the DACH region, accounting for 65.9% of the market in 2024, and has experienced a -39.2% decline from 2022 to 2023 but is expected to recover with a 13.9% increase in 2024.
Switzerland has seen a more moderate decline of -30.7% from 2022 to 2023, with a 14.0% projected increase in 2024. Austria, the most minor portion of the region, is expected to see a decrease of -2.2% in 2024.
The sectoral breakdown reveals that vacancies in the pharmaceutical industry across all three countries have gradually declined. In contrast, CRO and biotech follow the previous trends, with a dip and resurgence across 23/24.
Netherlands Rises, Belgium Falls: BENELUX Job Market Shifts
Examining the BENELUX region, the Netherlands’ share is increasing, rising from 43.3% in 2022 to 55.0% in 2024. Despite a -32.6% decline from 2022 to 2023, it is expected to recover with a 42.2% increase in 2024.
Belgium, though still significant, saw its share decrease from 56.6% in 2022 to 44.7% in 2024. Belgium experienced a -39.1% decline from 2022 to 2023 and is projected to have a slight -2.1% decrease in 2024.
Pharmaceuticals remain the dominant sector, accounting for 56.0% of the market in 2022. This declined by 29.9% from 2022 to 2023 and 54.1% in the 2024 estimate, showing moderate decline and recovery.
Syneos Health leads the UK, while AstraZeneca leads the EU
Focusing now on the top ten countries in DACH specifically, for the second year in a row, Eurofins (a CRO company) has the most scientific vacancies. Over the past few years, they have seen significant growth, increasing 69.5% from 2022 to 2023 and projected to grow another 40.8% in 2024.
For BENELUX, the fastest growing company is Merck, with an increase in vacancies by 39.2%. The second highest is instead Johnson & Johnson. They have remained relatively stable, with a 3.6% decline from 2022 to 2023 and no projected change in 2024.
GSK saw the most change year to year, with a high decline for the second year in a row, estimating -35.3% for the 2023-2024 year.
Uncover valuable insights on key Life Sciences labour market trends and download your copy below!
All data featured in this report is available in the Vacancy Analytics platform, which is updated in real-time and allows for interactive analysis, giving you the power to drill into trends to identify the key insights you need to power your business.
If you would like to book a consultation with us to analyse trends in your market, you can schedule one here.
